ロード中...

Suvorexant: The first orexin receptor antagonist to treat insomnia

Primary insomnia is mainly treated with drugs acting on benzodiazepine receptors and a few other classes of drugs used for different co-morbidities. A novel approach to treat insomnia has been introduced recently, with the approval of suvorexant, the first in a new class of orexin receptor antagonis...

詳細記述

保存先:
書誌詳細
出版年:J Pharmacol Pharmacother
主要な著者: Dubey, Ashok K., Handu, Shailendra S., Mediratta, Pramod K.
フォーマット: Artigo
言語:Inglês
出版事項: Medknow Publications & Media Pvt Ltd 2015
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4419247/
https://ncbi.nlm.nih.gov/pubmed/25969666
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0976-500X.155496
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!